These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22816133)

  • 1. Nanoparticle delivery strategies to target doxorubicin to tumor cells and reduce side effects.
    Wang Y; Wei X; Zhang C; Zhang F; Liang W
    Ther Deliv; 2010 Aug; 1(2):273-87. PubMed ID: 22816133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model.
    Wong HL; Rauth AM; Bendayan R; Wu XY
    Eur J Pharm Biopharm; 2007 Mar; 65(3):300-8. PubMed ID: 17156986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
    Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
    Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
    Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z
    J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticancer activity of galactoxyloglucan polysaccharide-conjugated doxorubicin nanoparticles: Mechanistic insights and interactome analysis.
    Joseph MM; Aravind SR; George SK; Raveendran Pillai K; Mini S; Sreelekha TT
    Eur J Pharm Biopharm; 2015 Jun; 93():183-95. PubMed ID: 25864443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-density lipoprotein peptide-combined DNA nanocomplex as an efficient anticancer drug delivery vehicle.
    Zhang N; Tao J; Hua H; Sun P; Zhao Y
    Eur J Pharm Biopharm; 2015 Aug; 94():20-9. PubMed ID: 25960329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and evaluation of clickable gelatin-oleic nanoparticles using fattigation-platform for cancer therapy.
    Meghani NM; Amin HH; Park C; Park JB; Cui JH; Cao QR; Lee BJ
    Int J Pharm; 2018 Jul; 545(1-2):101-112. PubMed ID: 29698822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surfactant-polymer nanoparticles: a novel platform for sustained and enhanced cellular delivery of water-soluble molecules.
    Chavanpatil MD; Khdair A; Panyam J
    Pharm Res; 2007 Apr; 24(4):803-10. PubMed ID: 17318416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipomer of doxorubicin hydrochloride for enhanced oral bioavailability.
    Benival DM; Devarajan PV
    Int J Pharm; 2012 Feb; 423(2):554-61. PubMed ID: 22155412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Charge-conversional and reduction-sensitive poly(vinyl alcohol) nanogels for enhanced cell uptake and efficient intracellular doxorubicin release.
    Chen W; Achazi K; Schade B; Haag R
    J Control Release; 2015 May; 205():15-24. PubMed ID: 25445693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug delivery systems using polymer nanoassemblies for cancer treatment.
    Bae Y
    Ther Deliv; 2010 Sep; 1(3):361-3. PubMed ID: 22816139
    [No Abstract]   [Full Text] [Related]  

  • 12. Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity.
    Jung SH; Jung SH; Seong H; Cho SH; Jeong KS; Shin BC
    Int J Pharm; 2009 Dec; 382(1-2):254-61. PubMed ID: 19666094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetically triggered drug release from nanoparticles and its applications in anti-tumor treatment.
    Hua X; Yang Q; Dong Z; Zhang J; Zhang W; Wang Q; Tan S; Smyth HD
    Drug Deliv; 2017 Nov; 24(1):511-518. PubMed ID: 28181827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folate-mediated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting drug delivery.
    Zhang C; Zhao L; Dong Y; Zhang X; Lin J; Chen Z
    Eur J Pharm Biopharm; 2010 Sep; 76(1):10-6. PubMed ID: 20472060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pH-Sensitive nanoparticles as smart carriers for selective intracellular drug delivery to tumor.
    Li XX; Chen J; Shen JM; Zhuang R; Zhang SQ; Zhu ZY; Ma JB
    Int J Pharm; 2018 Jul; 545(1-2):274-285. PubMed ID: 29733971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced tumor uptake and activity of nanoplex-loaded doxorubicin.
    Zhao N; Leng Q; Woodle MC; Mixson AJ
    Biochem Biophys Res Commun; 2019 May; 513(1):242-247. PubMed ID: 30954222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodegradable chimaeric polymersomes mediate highly efficient delivery of exogenous proteins into cells.
    Cheng R; Liu G; Ma S; Li S; Meng F; Liu H; Zhong Z
    J Control Release; 2011 Nov; 152 Suppl 1():e136-7. PubMed ID: 22195804
    [No Abstract]   [Full Text] [Related]  

  • 18. Preparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles.
    Dreis S; Rothweiler F; Michaelis M; Cinatl J; Kreuter J; Langer K
    Int J Pharm; 2007 Aug; 341(1-2):207-14. PubMed ID: 17478065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A folate modified pH sensitive targeted polymeric micelle alleviated systemic toxicity of doxorubicin (DOX) in multi-drug resistant tumor bearing mice.
    Li X; Yang X; Lin Z; Wang D; Mei D; He B; Wang X; Wang X; Zhang Q; Gao W
    Eur J Pharm Sci; 2015 Aug; 76():95-101. PubMed ID: 25917524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH-sensitive biocompatible block copolymer vesicles for drug delivery.
    Du J; Tang Y; Lewis AL; Armes SP
    J Control Release; 2011 Nov; 152 Suppl 1():e16-7. PubMed ID: 22195821
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.